CSL Limited (OTCMKTS:CSLLY – Get Free Report)’s stock price shot up 0.2% on Friday . The stock traded as high as $91.91 and last traded at $91.19. 32,278 shares were traded during trading, a decline of 13% from the average session volume of 37,233 shares. The stock had previously closed at $91.05.
CSL Trading Up 0.2 %
The business’s 50-day simple moving average is $91.65 and its 200-day simple moving average is $90.20.
About CSL
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Stories
- Five stocks we like better than CSL
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Canadian Penny Stocks: Can They Make You Rich?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Stock Market Upgrades: What Are They?
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for CSL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL and related companies with MarketBeat.com's FREE daily email newsletter.
